Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
NIH 2012 Budget
NIH faces the prospect of going the entire 2012 fiscal year without an approved budget. Congressional leaders have dropped plans to set funding for NIH and the rest of the U.S. Department of Health and Human Services (HHS) through a Labor-HHS-Education spending bill. Instead, they are looking to fund Labor-HHS-Education through one or more stopgap “continuing resolutions” (CRs); the current CR expires on Dec. 16. The possible CR adds to the uncertainty over NIH’s future spending, which emerged just before Thanksgiving when the Congressional “supercommittee” failed to craft a deficit-cutting plan for the following decade. As a result, NIH and other nondefense agencies face a 7.8% cut in 2013. What are your predictions for NIH next year?